Pancreatic Cancer Research

ResearcherThe University of OsakaNo recent work listed

Hideshi Ishii

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7191-6943; OpenAlex author ID A5103144395. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 2

  1. A Hydrogen Peroxide Activatable Gemcitabine Prodrug for the Selective Treatment of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/cmdc.201900324↗
  2. Susceptibility of pancreatic cancer stem cells to reprogramming. Last author DOI 10.1111/cas.12734↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuichiro Doki · 2 shared papers, 2015–2019 · strength 0.12
  2. Hidetoshi Eguchi · 2 shared papers, 2015–2019 · strength 0.12
  3. Tadafumi Asaoka · 1 shared paper, 2019 · strength 0.07
  4. Ayumu Asai · 1 shared paper, 2019 · strength 0.07
  5. Yoshifumi Iwagami · 1 shared paper, 2019 · strength 0.07
  6. Hirofumi Akita · 1 shared paper, 2019 · strength 0.07
  7. Daisaku Yamada · 1 shared paper, 2019 · strength 0.07
  8. Satoshi Obika · 1 shared paper, 2019 · strength 0.07
  9. Kunihito Gotoh · 1 shared paper, 2019 · strength 0.07
  10. Katsunori Matsushita · 1 shared paper, 2019 · strength 0.07
  11. Kozo Noguchi · 1 shared paper, 2015 · strength 0.05
  12. Shigeru Marubashi · 1 shared paper, 2015 · strength 0.05
  13. Hiroaki Nagano · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.